Definitive Healthcare Corp. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
08 Settembre 2023 - 10:05PM
Definitive Healthcare (Nasdaq: DH), an industry leader in
healthcare commercial intelligence, today announced that in
connection with Definitive Healthcare’s acquisition of Populi, Inc.
(“Populi”), effective September 6, 2023, the Human Capital
Management and Compensation Committee (the “Committee”) of
Definitive Healthcare’s Board of Directors granted inducement
awards consisting of 551,758 performance-based restricted stock
units (“PSUs”) and 274,728 time-based restricted stock units
(“RSUs”) to 30 former employees of Populi. These awards include
137,363 PSUs (the “Moschella PSUs”) and 201,467 RSUs (the
“Moschella RSUs”) granted to William Moschella, as well as 45,788
PSUs (the “Salmon PSUs”) and 73,261 RSUs (the “Salmon RSUs”)
granted to Nathan Salmon, which were individually negotiated. The
awards were granted as an inducement material to such individuals’
commencement of employment with Definitive Healthcare in accordance
with Nasdaq Listing Rule 5635(c)(4).
The awards are subject to the terms and conditions of Definitive
Healthcare’s 2023 Inducement Plan (the “Plan”) and the terms
and conditions of an applicable award agreement covering the grant.
Except as described below, the PSUs become earned based on
performance against certain financial objectives for each of
calendar years 2023, 2024, and 2025 (each, a “Performance Period”),
and shall vest upon the Committee’s certification of the extent to
which the performance goals were attained for the applicable
Performance Period, subject to the recipient’s continued service
(as defined in the Plan) through the date of such
certification.
The Moschella PSUs and the Salmon PSUs become earned based on
performance against certain financial objectives for calendar year
2023 and shall vest upon the Committee’s certification of the
extent to which the performance goals were attained, subject to the
recipient’s continued service through the date of such
certification. The Salmon RSUs and 109,891 of the Moschella RSUs
vest in three equal installments, with one third of the underlying
shares vesting on each of January 1, 2024, January 1, 2025, and
January 1, 2026, subject to the recipient’s continued service
through such date. The remaining 91,576 Moschella RSUs vest as
follows: 50% of the underlying shares will vest on August 1, 2024,
with the remaining shares vesting in four equal quarterly
installments thereafter.
About Definitive Healthcare
At Definitive Healthcare, our passion is to transform data,
analytics and expertise into healthcare commercial intelligence. We
help clients uncover the right markets, opportunities and people,
so they can shape tomorrow’s healthcare industry. Our SaaS platform
creates new paths to commercial success in the healthcare market,
so companies can identify where to go next. Learn more at
definitivehc.com.
Investor Relations Contact:Brian DenyeauICR for
Definitive Healthcarebrian.denyeau@icrinc.com 646-277-1251
Media Contacts:Danielle
Johnsdjohns@definitivehc.com
Grafico Azioni Definitive Healthcare (NASDAQ:DH)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni Definitive Healthcare (NASDAQ:DH)
Storico
Da Giu 2023 a Giu 2024